Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Showing posts with label needlestick. Show all posts
Showing posts with label needlestick. Show all posts

Thursday, March 19, 2015

Australia: Prisons breeding ground for Hep C

Australian jails are a potential breeding ground for Hepatitis C, a former prison officer has told a Senate inquiry.

Ross Hannah says Australia could be gearing up for a tidal wave of liver transplants if more effort isn't put into preventing illicit drugs and syringes entering jails.

Mr Hannah said needle stick injuries were a growing threat to prison guards during cell searches.

Read more at http://www.9news.com.au/national/2015/03/20/10/24/prisons-breeding-ground-for-hep-c-guard#JPfueRARkZuckYLt.99

Wednesday, January 28, 2015

UK: Risk of blood-borne viruses from sharps injuries continues, report claims

Healthcare workers continue to be at risk of exposure to blood-borne viruses through occupational sharps injuries, with reported cases increasing, Public Health England (PHE) has warned in a damning report.

This is despite awareness of the risk of sharps injuries, safe practices being much more widespread, and the fact safety-engineered devices to prevent such injuries are now widely available, it has added.

In its latest report on exposures to a blood-borne virus (BBV), PHE said cases reported had increased among healthcare workers from 373 in 2004 to 496 in 2013.

The updated Eye of the Needle report, which was first published in 2012, found that, over this 10-year period, approximately 30% of exposures involved a source patient infected with HIV; 54% involved hepatitis C (HCV) and 9% hepatitis B (HBV).

Read more...